Ablynx Banks $200M IPO in Nasdaq Debut Post author:Sam Post published:October 24, 2017 Post category:BioPharma Ablynx announced the price of its U.S. IPO at $17.50. Source: BioSpace You Might Also Like FDA Demands Karyopharm Stop Enrollment of All Selinexor Trials March 12, 2017 Bio-Rad Release: Company To Report Fourth-Quarter And Full-Year 2016 Financial Results Thursday, February 23, 2017 January 18, 2017 3 Rock-Bottom Biotechs That Big Market Players are Betting On May 15, 2017
Bio-Rad Release: Company To Report Fourth-Quarter And Full-Year 2016 Financial Results Thursday, February 23, 2017 January 18, 2017
